American Chemical Society
cn7b00105_si_001.pdf (220.33 kB)

Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2

Download (220.33 kB)
journal contribution
posted on 2017-06-02, 00:00 authored by Shannon N. Mostyn, Jane E. Carland, Susan Shimmon, Renae M. Ryan, Tristan Rawling, Robert J. Vandenberg
It has been demonstrated previously that the endogenous compound N-arachidonyl-glycine inhibits the glycine transporter GlyT2, stimulates glycinergic neurotransmission, and provides analgesia in animal models of neuropathic and inflammatory pain. However, it is a relatively weak inhibitor with an IC50 of 9 μM and is subject to oxidation via cyclooxygenase, limiting its therapeutic value. In this paper we describe the synthesis and testing of a novel series of monounsaturated C18 and C16 acyl-glycine molecules as inhibitors of the glycine transporter GlyT2. We demonstrate that they are up to 28 fold more potent that N-arachidonyl-glycine with no activity at the closely related GlyT1 transporter at concentrations up to 30 μM. This novel class of compounds show considerable promise as a first generation of GlyT2 transport inhibitors.